Effect of Probiotics on Helicobacter Pylori Eradication
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the clinical efficacy of Bifidobacterium
quadruple live bacteria tablets (Si Lian Kang) on reducing the incidence rate of adverse
reactions of Helicobacter pylori quadruple eradication therapy and its influence on
gastrointestinal flora.
Phase:
Phase 4
Details
Lead Sponsor:
Hangzhou Grand Biologic Pharmaceutical, Inc.
Collaborators:
960th Hospital of People's Liberation Army Fifth Affiliated Hospital of Zhengzhou University Nanjing First Hospital, Nanjing Medical University Renmin Hospital of Wuhan University Sir Run Run Shaw Hospital, affiliated with Zhejiang University, School of Medicine The First Affiliated Hospital of Nanchang University The First Affiliated Hospital of Shanxi Medical University The First People's Hospital of Yunnan Xi'an Central Hospital Zhejiang Provincial Hospital of TCM